SIBN icon

SI-BONE Inc

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 62.5%
Negative

Negative
Zacks Investment Research
6 days ago
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
Si-Bone (SIBN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.11 per share a year ago.
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
Neutral
Seeking Alpha
6 days ago
SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript
SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript
SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
6 days ago
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025Generates free cash flow in the Fourth Quarter 2025
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
Neutral
GlobeNewsWire
12 days ago
SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026
SANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA. Management will be hosting a fireside chat on Monday, March 2, 2026, at 7:30 a.m. Pacific Time/ 10:30 a.m. Eastern Time.
SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026
Negative
Zacks Investment Research
14 days ago
Earnings Preview: Si-Bone (SIBN) Q4 Earnings Expected to Decline
Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Si-Bone (SIBN) Q4 Earnings Expected to Decline
Neutral
GlobeNewsWire
27 days ago
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the fourth quarter and full year ended December 31, 2025 after market close on Monday, February 23, 2026.
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
Neutral
GlobeNewsWire
1 month ago
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
Fiscal Year 2025 worldwide revenue of $200.8 to $200.9 million, representing growth of ~20% Fiscal Year 2025 worldwide revenue of $200.8 to $200.9 million, representing growth of ~20%
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
Positive
Zacks Investment Research
2 months ago
Should You Buy Si-Bone (SIBN) After Golden Cross?
After reaching an important support level, SiBone (SIBN) could be a good stock pick from a technical perspective. SIBN recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Should You Buy Si-Bone (SIBN) After Golden Cross?
Neutral
GlobeNewsWire
3 months ago
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025
SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York, NY. Management will be hosting a fireside chat on Tuesday, December 2, 2025, at 9:00 a.m. Pacific Time/ 12:00 p.m. Eastern Time.
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025
Positive
The Motley Fool
3 months ago
Why SI-Bone Stock Was Crushing It Today
The medical device maker posted a satisfying beat-and-raise third quarter. During the period, it managed to narrow its net loss considerably.
Why SI-Bone Stock Was Crushing It Today